QuickView for TATA box binding protein associated factor (TAF) (biogroup)

1. Response of breast tumors treated with docetaxel-capecitabine (+/- trastuzumab)
2. L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
3. Time course of induced neuron and nociceptor differentiation from pluripotent cells
4. L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
5. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)

There were no matches for TATA box binding protein associated factor (TAF)

There were no clinical trials for TATA box binding protein associated factor (TAF)